Funding

Dash Bio

United States · Biotech · Robotics

Dash Bio provides automated bioanalysis for preclinical and clinical drug testing.

Visit dash.bioFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$30MFreestyle Capital — Role not disclosedOak HC/FT — Role not disclosedSwift Ventures — Role not disclosed

Investors

Freestyle CapitalSeries AOak HC/FTSeries ASwift VenturesSeries A

Coverage

Aug 3, 2026Dash Bio · Series A

Similar companies

Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Enact IntelligenceEnact Intelligence develops robot intelligence that uses force and touch to improve physical manipulation.$30M · Pre-seed
Sourcesprojectstartups.com ↗